Skip to main content

memo - Magazine of European Medical Oncology

Ausgabe 1/2024

Inhalt (16 Artikel)

Prostate cancer special—part 2

  • editorial

Shahrokh F. Shariat

(Neo)adjuvant approaches: pavement on the road to cure—breast cancer

  • Open Access
  • short review

Eva Valentina Klocker

(Neo)adjuvant approaches in lung cancer—paving the road to a cure

  • Open Access
  • short review

Romana Wass, Maximilian Hochmair, David Lang, Andreas Horner, Bernd Lamprecht

Innovative therapeutic concepts for biliary tumors

  • Open Access
  • short review

Angela Djanani

Cancer of unknown primary—state of the art

  • Open Access
  • short review

Thorsten Fuereder

Management of oligometastatic prostate cancer

  • short review

Marcin Miszczyk, Aleksander Slusarczyk, Fahad Quhal, Jakob Klemm, Akihiro Matsukawa, Mikołaj Przydacz, Piotr Bryniarski, Shahrokh F. Shariat, Paweł Rajwa

Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review

  • Open Access
  • short review

Stephan Brönimann, Nirmish Singla, Stephan M Korn, Nicolai A Huebner, Shahrokh F Shariat

Metastasis-directed therapy: new standard or too early to change paradigm?

  • Open Access
  • short review

Jakob Klemm, Pawel Rajwa, Marcin Miszczyk, Stephan Brönimann, Ekaterina Laukhtina, Ichiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, Pierre I. Karakiewicz, Shahrokh F. Shariat

Genetic testing and management of prostate cancer patients with pathogenic germline variants

  • Open Access
  • short review

Katharina Reiter, Melanie R. Hassler

Renal crystal-storing histiocytosis successfully treated with bortezomib-based regimen

  • case report

Poornima Tadkal, Siddini Vishwanath, Vankalakunti Mahesha, Kishore Babu, Mallikarjun Kalashetty

Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer

  • Open Access
  • special report

Julia M. Berger, Pia Gattinger, Maximilian J. Mair, Anna S. Berghoff, Rudolf Valenta, Matthias Preusser